Form 4: Eastman Chemical Director Reports Phantom Stock Units

Brett D. Begemann, a Director at Eastman Chemical Co., reported the acquisition of unvested phantom stock units valued at $73.69 each, totaling 1,628 units, under the Directors' Deferred Compensation Plan.

Summary

• Director Brett D. Begemann has reported the acquisition of 1,628 unvested phantom stock units.
• These units are part of the Directors' Deferred Compensation Plan and are valued at $73.69 per unit.
• The phantom stock units will vest on May 7, 2027, and will be payable in cash.
• This transaction represents a deferral of the value of an annual non-employee director restricted stock award.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation disclosure for a director rather than a significant event impacting the company's financial performance or strategic direction.

Positives

• Director compensation plan continues to be utilized, indicating ongoing engagement and incentive structures for board members.
• The deferral mechanism suggests a long-term perspective from the director regarding the company's stock value.

Future Outlook

The phantom stock units are scheduled to vest on May 7, 2027, and will be settled in cash.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive and director compensation and ownership. The use of phantom stock units is a common incentive tool in the chemical industry to align director interests with shareholder value.

Stakeholder Impact

• Shareholders: Increased transparency into director compensation and potential alignment of interests.
• Employees: Indirect impact through the continued operation of executive and director incentive programs.
• Management: Reinforces the use of equity-based compensation as a retention and performance tool.

Next Steps

• The phantom stock units will vest on May 7, 2027.
• The vested units will be paid out in cash.

Key Dates

Keywords

Form 4, SEC Filing, Eastman Chemical, EMN, Director Compensation, Phantom Stock Units, Deferred Compensation Plan, Beneficial Ownership, Equity Award